Química Nova (Jan 2008)

HIV - recentes avanços na pesquisa de fármacos HIV - highlights in drug research

  • Wilson Cunico,
  • Claudia R. B. Gomes,
  • Walcimar T. Vellasco Junior

DOI
https://doi.org/10.1590/S0100-40422008000800035
Journal volume & issue
Vol. 31, no. 8
pp. 2111 – 2117

Abstract

Read online

The development of new antiretroviral drugs is a dynamic process that is continuously fueled by identification of new molecular targets and new compounds for know targets. The current available drugs can be classified into five categories: nucleoside analogues reverse transcriptase inhibitors, non-nucleoside reverse transcriptase inhibitors, protease inhibitors, integrase inhibitors and entry inhibitors (fusion inhibitors and CCR5 antagonist). In addition, the maturation inhibitors may be considered as potential target for chemotherapeutic intervention. This review presents some anti-HIV agents that have already gone through the advance development process for final approval for the treatment of AIDS.

Keywords